Latest net tangible assets for 6661.TWO: $280M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Welgene Biotech ,Ltd. (6661.TWO) currently reports a net tangible assets of $280M as of June 2026. That compares with $290M in the prior-year period — down 3.3% year over year. Use the charts on this page to explore Welgene Biotech ,Ltd.'s net tangible assets history and peer comparisons.
Welgene Biotech ,Ltd.'s net tangible assets decreased from $290M to $280M — a 3.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Welgene Biotech ,Ltd. reported $280M in net tangible assets as of June 2026. That compares with $290M in the prior-year period — down 3.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current net tangible assets of $280M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Welgene Biotech ,Ltd., and consider following 6661.TWO for alerts when major investors trade the stock.